Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study-Reference-Cited by-同舟云学术

Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study

Published:2017-05-26 Issue:7 Volume:24 Page:539-547
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Takeda Masayuki¹,Yokoyama Osamu²,Yoshida Masaki³,Nishizawa Osamu⁴,Hirata Kinya⁵,Nakaoka Ryuhei⁶,Takita Yasushi⁷,Murakami Masahiro⁸

Affiliation:

1. Department of Urology; Division of Clinical Research; Graduate Faculty of Interdisciplinary Research; University of Yamanashi; Yamanashi Japan

2. Department of Urology; Faculty of Medical Science; University of Fukui; Fukui Japan

3. Department of Urology; National Center for Geriatrics and Gerontology; Obu Japan

4. Department of Urology; North Alps Medical Center Azumi Hospital; Kitaazumigun Ikedamachi Japan

5. Clinical Development Department Tokyo; Nippon Shinyaku; Tokyo Japan

6. Biostatistics and Data Management Department; Nippon Shinyaku; Kyoto Japan

7. Asia-Pacific Statistical Science, Medicines Development Unit-Japan; Eli Lilly Japan; Kobe Japan

8. Medicines Development Unit; Eli Lilly and Company; Indianapolis Indiana USA

Funder

Nippon Shinyaku

Eli Lilly Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13357/fullpdf

Reference24 articles.

1. Burden of benign prostatic hyperplasia among men in Japan: patient-reported outcomes among those diagnosed and experiencing symptoms;Yoshida;Int. J. Urol.,2015

2. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur. Urol.,2013

3. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project;Verhamme;Eur. Urol.,2003

4. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients;Traish;J. Sex. Med.,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan;International Journal of Clinical Pharmacy;2023-09-15

2. A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia;Arab Journal of Urology;2023-06-13

3. Association between α1-adrenoceptor antagonists and delirium: Analysis of the Japanese Adverse Event Report database;2023-04-21

4. Discontinuation Rates of Tadalafil Alone and in Combination with a-Blockers in the Treatment of Male Lower Urinary Tract Symptoms with or without Coexisting Erectile Dysfunction: A Systematic Review and Meta-Analysis;International Journal of Clinical Practice;2022-11-03

5. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07